On December 13, 2016, the 21st Century Cures Act established (and the 2017 Food and Drug Administration Reauthorization Act later amended) a requirement that sponsors of one or more investigational ...
Marking an impressive milestone in the development of MDMA-assisted psychotherapy for PTSD, the U.S. Food and Drug Administration (FDA) has approved the treatment for Expanded Access, allowing certain ...
The U.S. Food and Drug Administration (FDA) informed the company that an expanded access protocol for NVG-291 may proceed This news release constitutes a "designated news release" for the purposes of ...
“Let it grow, let it blossom,” said Eric Clapton, and so the Food and Drug Administration expects of expanded access programs with the issuance of its guidance on “Expanded Access to Investigational ...
As the winds of change blow away the lingering odors of the “right to try” miasma, it’s time to get serious about expanded access 2.0. Last week, more than 500 people from industry, academia, ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Some patients facing death take drastic, or even desperate measures in order to prolong their lives. Such actions often include taking unapproved, investigational drugs. In the U.S., a program known ...
One night in November 2018, I fell while crossing a street in Subic Bay, a U.S. naval logistics station in The Philippines. My face whacked the asphalt. Lying in the path of oncoming traffic, I couldn ...
Patients with lower risk myelodysplastic syndrome may now receive imetelstat — despite it not being FDA-approved. Patients with lower risk myelodysplastic syndrome (MDS) — a type of cancer that starts ...
You’ve got a drug in the pipeline that’s showing great promise. Results from your clinical trials are making news. What happens when you start getting calls from physicians and desperately ill ...
Individual patient expanded access, sometimes termed “compassionate use,” refers to situations where access to a drug still in the development process is granted to patients on a case-by-case basis ...
An easier application process could make experimental drugs more accessible to patients in need — outside the realm of clinical trials. “I’M SORRY, BUT THERE isn’t anything else I can do for you ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results